All Stories

  1. Later age of natural menopause among women with the pathogenic CHEK2 c.1100delC variant: a validation study

    Article • Journal of Medical Genetics, February 2026, BMJ

    Jenny Visser

  2. The impact of immune checkpoint inhibitors on gonadal function in patients with solid tumors

    Article • ESMO Open, January 2026, Elsevier

    Jenny Visser

  3. AMH as a marker for resumption of ovarian function after chemotherapy: an IPD meta-analysis and systematic review

    Article • Cancer Treatment Reviews, January 2026, Elsevier

    Jenny Visser

  4. Functional characterisation of obesity-associated MRAP2 variants on MC4R and GHSR signalling

    Article • Human Molecular Genetics, January 2026, Oxford University Press (OUP)

    Jenny Visser

  5. 11-Oxygenated Androgens Inhibit Brown Adipose Tissue Differentiation

    Article • Endocrinology, November 2025, Endocrine Society

    Jenny Visser

  6. Sex differences in leptin levels in children and adolescents with normal weight and overweight/obesity across pubertal stages: a systematic review and meta-analysis

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2025, Endocrine Society

    Jenny Visser

  7. SUL-138 mitigates accelerated endothelial aging and protects the kidney

    Article • Clinical Science, November 2025, Portland Press Ltd.

    Jenny Visser

  8. Early prediction of menopausal status after chemotherapy in women with early breast cancer in order to optimize adjuvant endocrine therapy

    Article • The Breast, October 2025, Elsevier

    Jenny Visser

  9. Sex steroids and women’s physical performance in midlife: Findings from the Menarche-to-PreMenopause Study

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2025, Endocrine Society

    Jenny Visser

  10. Role of mitochondrial function in the oxidative stress profile of children with Prader-Willi syndrome

    Article • Free Radical Biology and Medicine, September 2025, Elsevier

    Jenny Visser

  11. POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Genetics of polycystic ovary syndrome (PCOS)

    Article • Reproduction, August 2025, Bioscientifica

    Jenny Visser

  12. Navigating the Strengths and Constraints of Mouse Models in Obesity Research

    Article • Endocrinology, July 2025, Endocrine Society

    Jenny Visser

  13. The Role of Anti-Müllerian Hormone in Ovarian Function

    Article • Seminars in Reproductive Medicine, May 2024, Thieme Publishing Group

    Jenny Visser

  14. OR0303 Syndecans Enhance Ghrelin-Induced GHSR1a Signaling

    Article • Journal of the Endocrine Society, October 2023, Endocrine Society

    Jenny Visser

  15. Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2022, Endocrine Society

    Jenny Visser

  16. Comparison of three different AMH assays with AMH levels and follicle count in women with polycystic ovary syndrome

    Article • Endocrine Abstracts, May 2022, Bioscientifica

    Jenny Visser

  17. Association between an AMH promoter polymorphism and serum AMH levels in PCOS patients

    Article • Human Reproduction, April 2022, Oxford University Press (OUP)

    Jenny Visser

  18. Androgen receptor mutations modulate activation by 11-oxygenated androgens and glucocorticoids

    Article • Prostate Cancer and Prostatic Diseases, January 2022, Springer Science + Business Media

    Jenny Visser

  19. The importance of metabolic dysfunction in polycystic ovary syndrome

    Article • Nature Reviews Endocrinology, December 2020, Springer Science + Business Media

    Jenny Visser

  20. Serum AMH Levels: An Early Reproductive Marker for Bone Loss?

    Article • Journal of Bone and Mineral Research, December 2020, Oxford University Press (OUP)

    Jenny Visser

  21. Current insights into the genetics of polycystic ovary syndrome

    Article • Endocrine Abstracts, August 2020, Bioscientifica

    Jenny Visser

  22. Association between an AMH promoter polymorphism and serum AMH levels in PCOS patients

    Article • Endocrine Abstracts, August 2020, Bioscientifica

    Jenny Visser

  23. AMH in PCOS: Controlling the ovary, placenta, or brain?

    Article • Current Opinion in Endocrine and Metabolic Research, June 2020, Elsevier

    Jenny Visser

  24. SUN-008 Loss of Antimullerian Hormone Immunoreactivity Due to a Homozygous AMH Gene Mutation Rs10417628 in a Woman with Classical Polycystic Ovary Syndrome

    Article • Journal of the Endocrine Society, April 2020, Endocrine Society

    Jenny Visser

  25. Fetal antecedents of PCOS: is there a role of AMH?

    Article • Endocrine Abstracts, November 2019, Bioscientifica

    Jenny Visser

  26. Homozygous antimullerian hormone (AMH) gene mutation rs10417628 in a polycystic ovary syndrome (PCOS) woman with exaggerated hyperandrogenism

    Article • Fertility and Sterility, September 2019, Elsevier

    Jenny Visser

  27. MON-208 Association Study of AMH Promoter Polymorphisms and Serum AMH Levels in PCOS Patients

    Article • Journal of the Endocrine Society, April 2019, Endocrine Society

    Jenny Visser

  28. Multiple effects of cold exposure on livers of male mice

    Article • Journal of Endocrinology, August 2018, Bioscientifica

    Jenny Visser

  29. Sex differences in glucocorticoid-induced metabolic disturbances in mice

    Article • Endocrine Abstracts, May 2018, Bioscientifica

    Jenny Visser

  30. Associations Between Systemic and Local Corticosteroid Use With Metabolic Syndrome and Body Mass Index

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2017, Endocrine Society

    Jenny Visser, Elisabeth van Rossum

  31. The Acylated/Unacylated Ghrelin Ratio Is Similar in Patients With Acromegaly During Different Treatment Regimens

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2017, Endocrine Society

    Jenny Visser

  32. The Steroid Metabolome in the Isolated Ovarian Follicle and Its Response to Androgen Exposure and Antagonism

    Article • Endocrinology, February 2017, Endocrine Society

    Prof Wiebke Arlt, Jenny Visser

  33. Menopause: Genome stability as new paradigm

    Article • Maturitas, October 2016, Elsevier

    Jenny Visser

  34. Metabolic dysfunction in a rodent model of PCOS

    Article • Endocrine Abstracts, May 2016, Bioscientifica

    Jenny Visser

  35. Shaping up the function of anti-Müllerian hormone in ovaries of mono-ovulatory species

    Article • Human Reproduction, May 2016, Oxford University Press (OUP)

    Jenny Visser

  36. Evidence that neuropeptide FF receptor type 1 is not the physiological unacylated ghrelin receptor

    Article • Hormone Molecular Biology and Clinical Investigation, January 2016, De Gruyter

    Jenny Visser

  37. Mouse models to study polycystic ovary syndrome: A possible link between metabolism and ovarian function?

    Article • Reproductive Biology, March 2014, Elsevier

    Jenny Visser

  38. Role of anti-Müllerian hormone and bone morphogenetic proteins in the regulation of FSH sensitivity

    Article • Molecular and Cellular Endocrinology, January 2014, Elsevier

    Jenny Visser

  39. Limitations and pitfalls of antimüllerian hormone measurements

    Article • Fertility and Sterility, October 2012, Elsevier

    Jenny Visser

  40. Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency

    Article • Nature Reviews Endocrinology, January 2012, Nature

    Jenny Visser

  41. A Novel <b><i>AMH</i></b> Missense Mutation in a Patient with Persistent Müllerian Duct Syndrome

    Article • Sexual Development, January 2012, Karger Publishers

    Jenny Visser

  42. Anti-Müllerian hormone (AMH): Regulator and marker of ovarian function

    Article • Annales d Endocrinologie, May 2010, Elsevier

    Jenny Visser

  43. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome

    Article • Human Reproduction, October 2008, Oxford University Press (OUP)

    Jenny Visser

  44. A Functional Anti-Müllerian Hormone Gene Polymorphism Is Associated with Follicle Number and Androgen Levels in Polycystic Ovary Syndrome Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2008, Endocrine Society

    Jenny Visser

  45. Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?

    Article • Reproductive BioMedicine Online, January 2008, Elsevier

    Jenny Visser

  46. AMH TYPE II RECEPTOR DEFICIENT MICE DISPLAY A MORE SEVERE OVARIAN PHENOTYPE THAN AMH DEFICIENT MICE

    Article • Biology of Reproduction, July 2007, Oxford University Press (OUP)

    Jenny Visser

  47. Anti-Müllerian hormone and folliculogenesis

    Article • Molecular and Cellular Endocrinology, April 2005, Elsevier

    Jenny Visser

  48. AMH signaling: from receptor to target gene

    Article • Molecular and Cellular Endocrinology, December 2003, Elsevier

    Jenny Visser

  49. Anti-Müllerian hormone and its role in ovarian function

    Article • Molecular and Cellular Endocrinology, December 2003, Elsevier

    Jenny Visser

  50. Regulation of ovarian function: the role of anti-Mullerian hormone

    Article • Reproduction, November 2002, Bioscientifica

    Jenny Visser

  51. Downstream factors in transforming growth factor-β family signaling

    Article • Molecular and Cellular Endocrinology, November 1998, Elsevier

    Jenny Visser